Drug profile · INN
measles, mumps, rubella and varicella vaccine (live)
PROQUAD
measles, mumps, rubella and varicella vaccine (live) (PROQUAD) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07BD54
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — measles, mumps, rubella and varicella vaccine (live)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
measles, mumps, rubella and varicella vaccine (live) (PROQUAD) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN measles, mumps, rubella and varicella vaccine (live)
Brand PROQUAD
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BD54
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is measles, mumps, rubella and varicella vaccine (live)?
measles, mumps, rubella and varicella vaccine (live) (PROQUAD) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for measles, mumps, rubella and varicella vaccine (live)?
PROQUAD is a marketed brand name for measles, mumps, rubella and varicella vaccine (live). Check FDA Drugs@FDA for the current US label holder and prescribing information.